Bourgier, Celine <br/><br/>
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  06 2019 
 - 365-373 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2019.02.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Confidence Intervals<br/>Dermatologic Agents--adverse effects<br/>Fibrosis<br/>Head and Neck Neoplasms--radiotherapy<br/>Humans<br/>Pravastatin--adverse effects<br/>Prospective Studies<br/>Quality of Life<br/>Radiation Injuries--drug therapy<br/>Skin--pathology<br/>Squamous Cell Carcinoma of Head and Neck--radiotherapy